In a cohort of 1200 Ashkenazi Jewish PD patients, genotyping for 10 GBA1 polymorphisms, LRRK2-G2019S and SMPD1-L302P revealed that E326K GBA1 notably increased the risk for PD when co-occurring with another mutation [37]. Here, LRRK2 is linked to Parkinson disease.